Search results
Showing 106 to 120 of 214 results for arthritis
Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee (IPG493)
Evidence-based recommendations on arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee. This involves using a radiofrequency probe to heat and smooth any defects and rough edges in the cartilage.
Find out more about NICE technology appraisals advisory committee D members
Filgotinib for treating moderately to severely active ulcerative colitis (TA792)
Evidence-based recommendations on filgotinib (Jyseleca) for moderately to severely active ulcerative colitis in adults when conventional or biological treatment cannot be tolerated, or the disease has responded inadequately or lost response to treatment.
Psoriatic arthritis (moderate to severe) - leflunomide [ID391]
Discontinued Reference number: GID-TAG385
Metatarsophalangeal joint replacement of the hallux (IPG140)
Evidence-based recommendations on metatarsophalangeal joint replacement of the hallux. This involves removing the problem joint and replacing it with an artificial one.
View recommendations for IPG140Show all sections
Sections for IPG140
Mosaicplasty for symptomatic articular cartilage defects of the knee (IPG607)
Evidence-based recommendations on mosaicplasty in people with symptomatic articular cartilage defects of the knee. This involves taking healthy cartilage from the edge of the joint and inserting it into drilled tunnels in the damaged site.
View recommendations for IPG607Show all sections
Discontinued Reference number: GID-TAG418
Denosumab for the prevention of osteoporotic fractures in postmenopausal women (TA204)
Evidence-based recommendations on denosumab (Prolia) for preventing osteoporotic fragility fractures in postmenopausal women.
Infliximab for acute exacerbations of ulcerative colitis (TA163)
Evidence-based recommendations on infliximab (Remicade) for treating acute exacerbations of severely active ulcerative colitis in adults.
This guideline covers care before, during and after a planned knee, hip or shoulder replacement. It includes recommendations to ensure that people are given full information about their options for surgery, including anaesthesia. It offers advice for healthcare professionals on surgical procedures and ensuring safety during operations. It also offers guidance on providing support and rehabilitation before and after surgery.
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (IPG230)
Evidence-based recommendations on arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis. This involves flushing the joint with fluid, which is introduced through small incisions in the knee.
View recommendations for IPG230Show all sections
Sections for IPG230
Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.
View recommendations for TA160Show all sections
guidance Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip Number TA304 Date issued February 2014
Single-step scaffold insertion for repairing symptomatic chondral knee defects (IPG793)
Evidence-based recommendations on single-step scaffold insertion for repairing symptomatic chondral knee defects. This involves inserting a scaffold into the damaged area of the knee to support regrowth and repair of the cartilage.
View recommendations for IPG793Show all sections
Evidence-based recommendations on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). This involves replacing damaged cartilage with an artificial (synthetic) implant.
View recommendations for IPG727Show all sections